World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
18514
World Ranking
3196
National Ranking
273

Pontiano Kaleebu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pontiano Kaleebu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 439 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pontiano Kaleebu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pontiano Kaleebu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Pontiano Kaleebu is affiliated with the London School of Hygiene & Tropical Medicine in the United Kingdom. Their research work primarily spans the fields of Medicine and Immunology and Microbiology, with a strong emphasis on Infectious Diseases, Virology, and Epidemiology. Molecular Biology and Immunology also represent significant areas within their research focus.

The main topics explored by Pontiano Kaleebu include HIV Research and Treatment, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research, and HIV/AIDS drug development and treatment. Additional areas of interest cover Vaccine Coverage and Hesitancy, studies of Viral Infections and Outbreaks, and the intersection of HIV, Drug Use, and Sexual Risk.

Among their recent papers are:

  • Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality, 2023, New England Journal of Medicine
  • Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts, 2021, International Journal of Infectious Diseases
  • Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial, 2022, The Lancet HIV
  • Uganda's experience in Ebola virus disease outbreak preparedness, 2018-2019, 2020, Globalization and Health
  • Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples, 2020, International Journal of Infectious Diseases

Frequent co-authors in Pontiano Kaleebu's work include Jennifer Serwanga, Deogratius Ssemwanga, Emily L. Webb, Janet Seeley, and Alison M. Elliott.

The scientist commonly publishes in several venues, including bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, SSRN Electronic Journal, International Journal of Infectious Diseases, and Viruses.

Pontiano Kaleebu has been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • The trans-ancestral genomic architecture of glycemic traits

    Ji Chen;Ji Chen;Cassandra N. Spracklen;Cassandra N. Spracklen;Gaëlle Marenne;Gaëlle Marenne;Arushi Varshney

  • HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

    Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie

  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

    Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

  • Effect of Human Immunodeficiency Virus (HIV) Type 1 Envelope Subtypes A and D on Disease Progression in a Large Cohort of HIV-1—Positive Persons in Uganda

    Pontiano Kaleebu;Pontiano Kaleebu;Neil French;Cedric Mahe;David Yirrell

  • HIV subtype diversity worldwide.

    Nicholas Bbosa;Pontiano Kaleebu;Pontiano Kaleebu;Deogratius Ssemwanga;Deogratius Ssemwanga

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  • Short-course antiretroviral therapy in primary HIV infection.

    S Fidler;K Porter;F Ewings

  • Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

    Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor

  • Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

    Enoch Muyanja;Aloysius Ssemaganda;Pearline Ngauv;Rafael Cubas

  • Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis

    David G Dillon;David G Dillon;Deepti Gurdasani;Deepti Gurdasani;Johanna Riha;Johanna Riha;Kenneth Ekoru;Kenneth Ekoru

  • Randomised controlled trials for Ebola: practical and ethical issues

    Clement Adebamowo;Oumou Bah-Sow;Fred Binka;Roberto Bruzzone

  • A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.

    Eduan Wilkinson;Eduan Wilkinson;Marta Giovanetti;Marta Giovanetti;Houriiyah Tegally;James E. San

  • CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa

    Etienne Karita;Nzeera Ketter;Matt A. Price;Kayitesi Kayitenkore

  • HIV and syphilis prevalence and associated risk factors among fishing communities of Lake Victoria, Uganda.

    Gershim Asiki;Juliet Mpendo;Andrew Abaasa;Collins Agaba

  • High HIV incidence and socio-behavioral risk patterns in fishing communities on the shores of Lake Victoria, Uganda.

    Janet Seeley;Jessica Nakiyingi-Miiro;Anatoli Kamali;Juliet Mpendo

  • Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts

    Eskild Petersen;Francine Ntoumi;David S Hui;Aisha Abubakar

  • Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.

    Pontiano Kaleebu;Amanda Ross;Dilys Morgan;David Yirrell

  • Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

    P. Kaleebu;D. Pillay;A. S. Walker;V. Robertson

  • Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania.

    Zacchaeus Anywaine;Hilary Whitworth;Hilary Whitworth;Pontiano Kaleebu;George Praygod

  • Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae

    H. Chen;Z. Q. Xiang;Y. Li;R. K. Kurupati

  • A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia

    Annettee Nakimuli;Olympe Anne Chazara;Susan E Hiby;Lydia Farrell

  • Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization.

    J Weber;E M Fenyö;S Beddows;P Kaleebu

  • Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.

    Matt A. Price;Carole L. Wallis;Shabir Lakhi;Etienne Karita

  • Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.

    Unknown

  • The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis

    Grant R. Campbell;Eddy Pasquier;Jennifer Watkins;Veronique Bourgarel-Rey

  • A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

    Eduan Wilkinson;Marta Giovanetti;Marta Giovanetti;Houriiyah Tegally;James E San

Frequent Co-Authors

Janet Seeley
Janet Seeley London School of Hygiene & Tropical Medicine
Matthew Price
Matthew Price University of Vermont
Deenan Pillay
Deenan Pillay University College London
Alison M. Elliott
Alison M. Elliott London School of Hygiene & Tropical Medicine
Anatoli Kamali
Anatoli Kamali International AIDS Vaccine Initiative
Heiner Grosskurth
Heiner Grosskurth University of London
James A. G. Whitworth
James A. G. Whitworth London School of Hygiene & Tropical Medicine
Charles F. Gilks
Charles F. Gilks University of Queensland
Eduard J. Sanders
Eduard J. Sanders University of Oxford
Cissy Kityo
Cissy Kityo Joint Clinical Research Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which benefit from specialized nursing roles. For those interested in mental health, exploring cheapest online pmhnp certificate programs can be an affordable pathway to becoming a Psychiatric Mental Health Nurse Practitioner.

Nurses pursuing advanced clinical roles often seek higher degrees. Understanding the doctorate in nursing salary can help inform decisions about investing time and resources in a Doctor of Nursing Practice (DNP) program, with competitive compensation in many states.

Transitioning into specialized acute care fields is another avenue. Those already in primary care can enhance their qualifications by pursuing acute care nurse practitioner certification, enabling them to work with critically ill patients and complex conditions linked to immunological disorders.

For students seeking expedited education, accelerated np programs online offer flexible, accelerated routes to becoming nurse practitioners, which can complement a background in immunology and expand professional opportunities.

Best Scientists Citing Pontiano Kaleebu

Trending Scientists

Recently Published Articles